Clinical Study
Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease
Table 2
Lesion characteristics and coronary angiographic outcomes at baseline, immediately after and at 8 months after implantation of the endeavor zotarolimus-eluting stent in the 3- and 12-month DAPT groups.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RCA: right coronary artery; LAD: left coronary artery; LCX: left circumflex artery; RVD: reference vessel diameter; MLD: minimal lumen diameter; TLR: target lesion revascularization; TVR: target vessel revascularization; LMT: left main trunk; DAPT: dual antiplatelet therapy; DS: diameter stenosis; NS: not significant. |